LACK OF ASSOCIATION BETWEEN LIPOPROTEIN (A) CONCENTRATIONS AND CORONARY HEART-DISEASE MORTALITY IN DIABETES - THE WISCONSIN EPIDEMIOLOGIC-STUDY OF DIABETIC-RETINOPATHY

被引:88
作者
HAFFNER, SM
MOSS, SE
KLEIN, BEK
KLEIN, R
机构
[1] UNIV WISCONSIN, SCH MED, DEPT OPHTHALMOL, 600 HIGHLAND AVE, MADISON, WI 53792 USA
[2] UNIV TEXAS, HLTH SCI CTR, DEPT MED, DIV CLIN EPIDEMIOL, SAN ANTONIO, TX 78284 USA
来源
METABOLISM-CLINICAL AND EXPERIMENTAL | 1992年 / 41卷 / 02期
关键词
D O I
10.1016/0026-0495(92)90152-Z
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Recently, considerable data have suggested that lipoprotein (a) [Lp(a)] is a strong independent risk factor for coronary heart disease. Since Lp(a) is increased in both insulin-dependent diabetes mellitus (IDDM) and non-insulin-dependent diabetes mellitus (NIDDM), this study examined the relationship of Lp(a) concentrations to coronary heart disease (CHD) mortality in the 4-year follow-up of the Wisconsin Epidemiologic Study of Diabetic Retinopathy (WESDR). Twenty-four older-onset subjects and 11 younger-onset subjects who died of CHD (cases) before the age of 70 were matched by age, gender, and type of diabetes to subjects who remained alive (controls). The distribution and mean levels of Lp(a) in the cases and controls were very similar, suggesting a lack of association between Lp(a) concentrations and CHD mortality. Although the number of subjects was small, caution should be used in extrapolating results on Lp(a) relationships in nondiabetic subjects to diabetic subjects. © 1992.
引用
收藏
页码:194 / 197
页数:4
相关论文
共 30 条
[1]  
ARAUZ C, 1990, DIABETES S1, V39, pA64
[2]   THE PROSPECTIVE CARDIOVASCULAR MUNSTER (PROCAM) STUDY - PREVALENCE OF HYPERLIPIDEMIA IN PERSONS WITH HYPERTENSION AND OR DIABETES-MELLITUS AND THE RELATIONSHIP TO CORONARY HEART-DISEASE [J].
ASSMANN, G ;
SCHULTE, H .
AMERICAN HEART JOURNAL, 1988, 116 (06) :1713-1724
[3]  
BERG K, 1974, CLIN GENET, V6, P230
[4]   INCREASED SERUM LEVELS OF LIPOPROTEIN(A) IN DIABETES-MELLITUS AND THEIR REDUCTION WITH GLYCEMIC CONTROL [J].
BRUCKERT, E ;
DAVIDOFF, P ;
GRIMALDI, A ;
TRUFFERT, J ;
GIRAL, P ;
DOUMITH, R ;
THERVET, F ;
DEGENNES, JL .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1990, 263 (01) :35-36
[5]   QUANTITATION AND LOCALIZATION OF APOLIPOPROTEIN[A] AND APOLIPOPROTEIN-B IN CORONARY-ARTERY BYPASS VEIN GRAFTS RESECTED AT REOPERATION [J].
CUSHING, GL ;
GAUBATZ, JW ;
NAVA, ML ;
BURDICK, BJ ;
BOCAN, TMA ;
GUYTON, JR ;
WEILBAECHER, D ;
DEBAKEY, ME ;
LAWRIE, GM ;
MORRISETT, JD .
ARTERIOSCLEROSIS, 1989, 9 (05) :593-603
[6]   ASSOCIATION OF LEVELS OF LIPOPROTEIN LP(A), PLASMA-LIPIDS, AND OTHER LIPOPROTEINS WITH CORONARY-ARTERY DISEASE DOCUMENTED BY ANGIOGRAPHY [J].
DAHLEN, GH ;
GUYTON, JR ;
ATTAR, M ;
FARMER, JA ;
KAUTZ, JA ;
GOTTO, AM .
CIRCULATION, 1986, 74 (04) :758-765
[7]  
DURRINGTON PN, 1988, LANCET, V1, P1070
[8]   MORBIDITY AND MORTALITY IN DIABETICS IN FRAMINGHAM POPULATION - 16-YEAR FOLLOW-UP STUDY [J].
GARCIA, MJ ;
MCNAMARA, PM ;
GORDON, T ;
KANNELL, WB .
DIABETES, 1974, 23 (02) :105-111
[9]   DECREASE OF LIPOPROTEIN(A) WITH IMPROVED GLYCEMIC CONTROL IN IDDM SUBJECTS [J].
HAFFNER, SM ;
TUTTLE, KR ;
RAINWATER, DL .
DIABETES CARE, 1991, 14 (04) :302-307
[10]  
HAFFNER SM, IN PRESS METABOLISM